Featured Research

from universities, journals, and other organizations

Two proteins compete for one port on a growth factor; one promotes metastasis, the other blocks it

Date:
January 23, 2014
Source:
University of Texas M. D. Anderson Cancer Center
Summary:
Consider two drivers, each with a key that fits the same car. Driver 1 wants simply to turn on the ignition and leave the vehicle idling, ready and waiting to roll. Driver 2 wants to take it on a destructive joy ride. New cancer researchers have discovered that the same happens in our bodies between two proteins.

Consider two drivers, each with a key that fits the same car. Driver 1 wants simply to turn on the ignition and leave the vehicle idling, ready and waiting to roll. Driver 2 wants to take it on a destructive joy ride.

Such is the case with two proteins identified by scientists at The University of Texas MD Anderson Cancer Center that fit on to the same binding site on an important cellular growth factor receptor called FGFR2 with starkly different results.

"There is competition for binding to FGFR2 and one of the two competitors, phospholipase Cγ1 (Plcγ1), will increase cancer cell metastasis. The other protein inhibits the opportunity for this to occur," said John Ladbury, Ph.D., professor of Biochemistry and Molecular Biology.

Ladbury is senior author of a paper published Sunday online at Nature Structural & Molecular Biology that describes the competition, identifies Plγcl's role and its relationship to the metastasis-blocking growth factor receptor bound protein 2 (Grb2).

In a 2012 paper in the journal Cell, Ladbury and colleagues showed that Grb2 binds to FGFR2 and holds it in check, ready to be activated by a growth factor to signal other proteins. In performing this role, Grb2 blocks the binding of other proteins such as Plcγ1.

More Grb2, less Plcγ1 stymies metastasis

These interactions occur outside normal activation of FGFR2 by growth factors, so the protein with the highest concentration levels in the cell wins the contest to bind to FGFR, or fibroblast growth factor receptor 2, Ladbury said. "In cells with depleted Grb2 concentration, Plcγ1gets on the receptor, increasing cellular motility -- equipping cells to move, escape the tumor, invade other tissue and spread."

Quantifying the relative concentration of these two proteins in a patient's tumor, Ladbury said, might be developed into reliable markers for gauging the likelihood that the cancer will spread and guide treatment decisions.

For example, an analysis of an ovarian cancer patient's initial presentation could indicate early whether chemotherapy will be needed in addition to surgery to combat metastasis. Ovarian cancer patients with low Grb2 expression levels could have an increased risk that their cancer will spread.

Trade-off matters in at least 5 cancer types

Analysis of published data on 20 cancer cell lines including lung, ovarian, kidney, breast and colon cancers, showed that a cancer's metastatic potential is linked to the relative concentration of Plcγ1 and Grb2 expression. Overexpression of Plcγ1 and low expression of Grb2 resulted in a high likelihood of metastasis, while high Grb2 and low Plcγ1 indicated a low likelihood that the cancer will spread.

Ladbury and colleagues set out to explain this relationship and its apparent effect with a series of cell line experiments that showed:

  • Grb2 blocks the binding of Plcγ1 to FGFR2.
  • Both proteins connect with the same site on FGFR2, using a similar domain on each protein to connect to the growth factor receptor.
  • Binding to FGFR2 activates Plcγ1.
  • Overexpression of Plcγ1 leads to increased invasion of other tissues, a vital step in metastasis.

All of this action occurs in the cell's stable state, or homeostasis, before a growth factor stimulates FGFR2 into action, which is what made the team's 2012 finding so striking. The domain (SH3) that each protein uses to connect to FGFR2 is not used in normal signaling.

FGFR2 spans a cell's outer membrane, with its outer portion receiving growth factors and its inner region passing along activating signals that order other proteins to perform their functions. In this case, there's no active signaling in the usual sense, Ladbury said.

Crucial events occur in background activity of cells

"That a protein can find a receptor using its SH3 domain is an entirely new idea," Ladbury said. "There's a lot of background activity in cells, just to keep them ticking over and in the past we've kind of ignored what's happening there. Now we've shown that if these background activities are perturbed, they can lead to cancer."

The Ladbury group is pursuing these studies to quantify the respective amounts of Grb2, Plcγ1 and FGFR2 in cancer cell lines to assess what levels might be prognostic. In addition they are investigating other receptors for their potential to bind SH3-domain containing proteins to build up a bigger picture of what pathways are involved in maintaining the stable state in cells.


Story Source:

The above story is based on materials provided by University of Texas M. D. Anderson Cancer Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Zahra Timsah, Zamal Ahmed, Chi-Chuan Lin, Fernando A Melo, Loren J Stagg, Paul G Leonard, Prince Jeyabal, Jonathan Berrout, Roger G O'Neil, Mikhail Bogdanov, John E Ladbury. Competition between Grb2 and Plcγ1 for FGFR2 regulates basal phospholipase activity and invasion. Nature Structural & Molecular Biology, 2014; DOI: 10.1038/nsmb.2752

Cite This Page:

University of Texas M. D. Anderson Cancer Center. "Two proteins compete for one port on a growth factor; one promotes metastasis, the other blocks it." ScienceDaily. ScienceDaily, 23 January 2014. <www.sciencedaily.com/releases/2014/01/140123125842.htm>.
University of Texas M. D. Anderson Cancer Center. (2014, January 23). Two proteins compete for one port on a growth factor; one promotes metastasis, the other blocks it. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2014/01/140123125842.htm
University of Texas M. D. Anderson Cancer Center. "Two proteins compete for one port on a growth factor; one promotes metastasis, the other blocks it." ScienceDaily. www.sciencedaily.com/releases/2014/01/140123125842.htm (accessed September 30, 2014).

Share This



More Health & Medicine News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How 'Yes Means Yes' Defines Sexual Assault

How 'Yes Means Yes' Defines Sexual Assault

Newsy (Sep. 29, 2014) Aimed at reducing sexual assaults on college campuses, California has adopted a new law changing the standard of consent for sexual activity. Video provided by Newsy
Powered by NewsLook.com
Scientists May Have Found An Early Sign Of Pancreatic Cancer

Scientists May Have Found An Early Sign Of Pancreatic Cancer

Newsy (Sep. 29, 2014) Researchers looked at 1,500 blood samples and determined people who developed pancreatic cancer had more branched chain amino acids. Video provided by Newsy
Powered by NewsLook.com
Colo. Doctors See Cluster of Enterovirus Cases

Colo. Doctors See Cluster of Enterovirus Cases

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com
Dr.'s Unsure of Cause of Fast-Spreading Virus

Dr.'s Unsure of Cause of Fast-Spreading Virus

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins